These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27513462)

  • 21. Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α.
    Keremu A; Aini A; Maimaitirexiati Y; Liang Z; Aila P; Xierela P; Tusun A; Moming H; Yusufu A
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 28442599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular RNA circ-CHI3L1.2 modulates cisplatin resistance of osteosarcoma cells via the miR-340-5p/LPAATβ axis.
    Zhang Z; Zhou Q; Luo F; Zhou R; Xu J; Xiao J; Dai F; Song L
    Hum Cell; 2021 Sep; 34(5):1558-1568. PubMed ID: 34164774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A.
    Yu WC; Chen HH; Qu YY; Xu CW; Yang C; Liu Y
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31221814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro.
    Li G; Zhu Y
    Pathol Res Pract; 2019 May; 215(5):931-938. PubMed ID: 30777616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma.
    Chen R; Li X; He B; Hu W
    Mol Med Rep; 2017 Mar; 15(3):1326-1334. PubMed ID: 28138700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
    Zhu Z; Wang CP; Zhang YF; Nie L
    Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1.
    Yan H; Zhang B; Fang C; Chen L
    Anticancer Drugs; 2018 Jun; 29(5):440-448. PubMed ID: 29494357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
    Gao Y; Feng Y; Shen JK; Lin M; Choy E; Cote GM; Harmon DC; Mankin HJ; Hornicek FJ; Duan Z
    Sci Rep; 2015 Jun; 5():11365. PubMed ID: 26079799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of beclin1 affects the chemotherapeutic sensitivity of osteosarcoma.
    Wu W; Li W; Zhou Y; Zhang C
    Int J Clin Exp Pathol; 2014; 7(10):7114-22. PubMed ID: 25400807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-135b promotes proliferation, invasion and migration of osteosarcoma cells by degrading myocardin.
    Xu WG; Shang YL; Cong XR; Bian X; Yuan Z
    Int J Oncol; 2014 Nov; 45(5):2024-32. PubMed ID: 25190111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma.
    Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S
    Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1.
    Cheng C; Ding Q; Zhang Z; Wang S; Zhong B; Huang X; Shao Z
    J Cell Mol Med; 2020 May; 24(9):5274-5289. PubMed ID: 32207235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-214 modulates cisplatin sensitivity of osteosarcoma cells through regulation of anaerobic glycolysis.
    Song YD; Li DD; Guan Y; Wang YL; Zheng J
    Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):75-79. PubMed ID: 28980925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor.
    Liu W; Liu SY; He YB; Huang RL; Deng SY; Ni GX; Yu B
    Biomed Pharmacother; 2017 Mar; 87():621-627. PubMed ID: 28086136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance.
    Sevelda F; Mayr L; Kubista B; Lötsch D; van Schoonhoven S; Windhager R; Pirker C; Micksche M; Berger W
    J Exp Clin Cancer Res; 2015 Nov; 34():134. PubMed ID: 26526352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
    Zhang CL; Zhu KP; Shen GQ; Zhu ZS
    Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells.
    Huang H; Wang L; Li M; Wang X; Zhang L
    World J Surg Oncol; 2014 Aug; 12():255. PubMed ID: 25106434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma.
    He C; Sun Z; Hoffman RM; Yang Z; Jiang Y; Wang L; Hao Y
    Anticancer Res; 2019 Apr; 39(4):1711-1718. PubMed ID: 30952710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment and characterization of a cisplatin‑resistant human osteosarcoma cell line.
    Han T; Zhu X; Wang J; Zhao H; Ma Q; Zhao J; Qiu X; Fan Q
    Oncol Rep; 2014 Sep; 32(3):1133-9. PubMed ID: 25017716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma.
    Tang Z; Lu Y; Chen Y; Zhang J; Chen Z; Wang Q
    Technol Cancer Res Treat; 2021; 20():15330338211034262. PubMed ID: 34323141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.